- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 3, Pages 407
Publisher
MDPI AG
Online
2019-03-27
DOI
10.3390/cancers11030407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
- (2018) Emanuela Martino et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
- (2018) Katarzyna B. Hooks et al. HEPATOLOGY
- Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT
- (2018) Rong Li et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Addition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival
- (2018) Jacquelyn M. Powers et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Molecular bases of the poor response of liver cancer to chemotherapy
- (2018) Jose J.G. Marin et al. Clinics and Research in Hepatology and Gastroenterology
- Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
- (2018) Anna Tutusaus et al. Oncotarget
- Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
- (2018) Rocio I.R. Macias et al. Oncotarget
- Epigenetic events involved in OCT1-dependent impaired response of hepatocellular carcinoma to sorafenib
- (2018) Ruba Al-Abdulla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glutathione S‑transferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer
- (2018) Mingyue Zou et al. ONCOLOGY REPORTS
- Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation
- (2018) Jingling Jin et al. ONCOLOGY REPORTS
- Management of Hepatoblastoma: ICMR Consensus Document
- (2017) Sandeep Agarwala et al. INDIAN JOURNAL OF PEDIATRICS
- Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients
- (2017) Masami Yamauchi et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children’s Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children’s Oncology Group
- (2017) Allison F. O’Neill et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration
- (2017) Rebecka L Meyers et al. LANCET ONCOLOGY
- Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine
- (2017) Johan Nicolaï et al. PHARMACEUTICAL RESEARCH
- Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
- (2017) Jiejie Dong et al. PLoS One
- Downregulation of transcription factor GATA4 sensitizes human hepatoblastoma cells to doxorubicin-induced apoptosis
- (2017) Tea Soini et al. TUMOR BIOLOGY
- The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma
- (2017) Andreas Geier et al. Oncotarget
- Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells
- (2017) Sarah Guttmann et al. Oncotarget
- Mechanisms of Resistance to Chemotherapy in Gastric Cancer
- (2016) J.J.G. Marin et al. Anti-Cancer Agents in Medicinal Chemistry
- The relationship between platinum drug resistance and epithelial–mesenchymal transition
- (2016) Anamaria Brozovic ARCHIVES OF TOXICOLOGY
- Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
- (2016) Pavel Sumazin et al. HEPATOLOGY
- Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol
- (2016) Eiso Hiyama et al. JOURNAL OF PEDIATRIC SURGERY
- The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
- (2016) Emil Andreev et al. Scientific Reports
- Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms
- (2015) Guifang Yu et al. Cancer Cell International
- Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells
- (2015) Chih-Cheng Hsiao et al. CANCER LETTERS
- MRP1 and its role in anticancer drug resistance
- (2015) Jamie F. Lu et al. DRUG METABOLISM REVIEWS
- New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants
- (2015) Laura Gatti et al. DRUG RESISTANCE UPDATES
- Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds
- (2015) Venkata V.V.R. Marada et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma
- (2015) Carmen Nagel et al. EXPERIMENTAL CELL RESEARCH
- The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells
- (2015) Feng Lin et al. Journal of Cancer Research and Therapeutics
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
- (2015) Franco M. Muggia et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
- (2015) Francesca V. Negri et al. LIVER INTERNATIONAL
- Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma
- (2015) YING YU et al. ONCOLOGY REPORTS
- TALEN-induced disruption of Nanog expression results in reduced proliferation, invasiveness and migration, increased chemosensitivity and reversal of EMT in HepG2 cells
- (2015) AI QING YU et al. ONCOLOGY REPORTS
- Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells
- (2015) A. Rodríguez-Hernández et al. Redox Biology
- Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma
- (2015) Hidetoshi Hayashi et al. Oncotarget
- Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics
- (2014) Márton Jani et al. ARCHIVES OF TOXICOLOGY
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study
- (2014) Mario Scartozzi et al. INTERNATIONAL JOURNAL OF CANCER
- The genomic landscape of hepatoblastoma and their progenies with HCC-like features
- (2014) Melanie Eichenmüller et al. JOURNAL OF HEPATOLOGY
- Role and mechanisms of microRNA-503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells
- (2014) DONG WANG et al. Molecular Medicine Reports
- BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
- (2014) Wei-Chien Huang et al. PLoS One
- Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance
- (2014) Céline Narjoz et al. PLoS One
- Expression of P450 and nuclear receptors in normal and end-stage Chinese livers
- (2014) Hong Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Recent studies of 5-fluorouracil resistance in pancreatic cancer
- (2014) Wei-Bin Wang WORLD JOURNAL OF GASTROENTEROLOGY
- The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
- (2013) Jose JG Marin et al. ACTA PHARMACOLOGICA SINICA
- An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2
- (2013) Jun Terashima et al. BMC MOLECULAR BIOLOGY
- Expression ofSLC22A1variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
- (2013) Elisa Herraez et al. HEPATOLOGY
- Emerging role of nanog in tumorigenesis and cancer stem cells
- (2013) Luis E. IV Santaliz-Ruiz et al. INTERNATIONAL JOURNAL OF CANCER
- Current chemotherapeutic approaches for hepatoblastoma
- (2013) Kenichiro Watanabe International Journal of Clinical Oncology
- ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway
- (2013) Xiang-jun Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Modulation of OATP1B-Type Transporter Function Alters Cellular Uptake and Disposition of Platinum Chemotherapeutics
- (2013) C. S. Lancaster et al. MOLECULAR CANCER THERAPEUTICS
- A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT)
- (2013) Eiso Hiyama et al. PEDIATRIC SURGERY INTERNATIONAL
- Mechanisms regulating resistance to inhibitors of topoisomerase II
- (2013) Ram N. Ganapathi et al. Frontiers in Pharmacology
- Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites
- (2012) Sussan Ghassabian et al. BIOCHEMICAL PHARMACOLOGY
- Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts
- (2012) C Eicher et al. BRITISH JOURNAL OF CANCER
- NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial–mesenchymal transition in hepatocellular carcinoma cells
- (2012) Qi-Da Hu et al. CANCER LETTERS
- Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
- (2012) J. J.G. Marin et al. CURRENT CANCER DRUG TARGETS
- Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
- (2012) S.-M. He et al. CURRENT MEDICINAL CHEMISTRY
- Inhibition of OCTN2-Mediated Transport of Carnitine by Etoposide
- (2012) C. Hu et al. MOLECULAR CANCER THERAPEUTICS
- No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
- (2012) P. Martinez-Becerra et al. MOLECULAR PHARMACEUTICS
- Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737
- (2012) JUSTUS LIEBER et al. ONCOLOGY REPORTS
- Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: Stable radiographic disease with decreased AFP
- (2012) Anne M. Marsh et al. PEDIATRIC BLOOD & CANCER
- Chemotherapeutic approaches for newly diagnosed hepatoblastoma: Past, present, and future strategies
- (2012) Angela D. Trobaugh-Lotrario et al. PEDIATRIC BLOOD & CANCER
- Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy
- (2012) Sabrina Angelini et al. PHARMACOLOGICAL RESEARCH
- Multidrug Resistance Protein 2 Implicates Anticancer Drug-Resistance to Sorafenib
- (2011) Yoshihiko Shibayama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
- (2011) Zhe-Sheng Chen et al. FEBS Journal
- HGF/c-Met related activation of β-catenin in hepatoblastoma
- (2011) Rachel Purcell et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability
- (2011) Yuka Ueda et al. JOURNAL OF PEDIATRIC SURGERY
- Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1nu mice
- (2011) Carmen Eicher et al. LIVER INTERNATIONAL
- Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma
- (2011) Irene Schmid et al. PEDIATRIC BLOOD & CANCER
- Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells
- (2011) Justus Lieber et al. PEDIATRIC SURGERY INTERNATIONAL
- Interaction of Oxazaphosphorines with Multidrug Resistance-Associated Protein 4 (MRP4)
- (2010) Jing Zhang et al. AAPS Journal
- Development of a drug resistance model for hepatoblastoma
- (2010) Armeanu-Ebinger INTERNATIONAL JOURNAL OF ONCOLOGY
- Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin
- (2010) Sara Vander Borght et al. LIVER INTERNATIONAL
- Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation
- (2010) J. S. Lagas et al. MOLECULAR CANCER THERAPEUTICS
- New Clues for Nephrotoxicity Induced by Ifosfamide: Preferential Renal Uptake via the Human Organic Cation Transporter 2
- (2010) Giuliano Ciarimboli et al. MOLECULAR PHARMACEUTICS
- Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells
- (2010) Justus Lieber et al. PEDIATRIC BLOOD & CANCER
- Very important pharmacogene summary
- (2010) Laura M. Hodges et al. Pharmacogenetics and Genomics
- Expression of Human Organic Cation Transporter 3 in Kidney Carcinoma Cell Lines Increases Chemosensitivity to Melphalan, Irinotecan, and Vincristine
- (2009) Volodymyr Shnitsar et al. CANCER RESEARCH
- P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide
- (2009) J. S. Lagas et al. CLINICAL CANCER RESEARCH
- Increased expression of multidrug resistance–associated genes after chemotherapy in pediatric solid malignancies
- (2009) Takaharu Oue et al. JOURNAL OF PEDIATRIC SURGERY
- Human Multidrug Resistance Protein 7 (ABCC10) Is a Resistance Factor for Nucleoside Analogues and Epothilone B
- (2008) E. Hopper-Borge et al. CANCER RESEARCH
- Expression of 17β-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines
- (2008) T. Šmuc et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience
- (2008) Maretta De Ioris et al. EUROPEAN JOURNAL OF CANCER
- Liver stem cells and hepatocellular carcinoma
- (2008) Lopa Mishra et al. HEPATOLOGY
- Up-regulation of breast cancer resistance protein expression in hepatoblastoma following chemotherapy: A study in patients andin vitro
- (2008) Sara Vander Borght et al. HEPATOLOGY RESEARCH
- Redefining the Role of Doxorubicin for the Treatment of Children With Hepatoblastoma
- (2008) Marcio H. Malogolowkin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation
- (2008) A. Kadenhe-Chiweshe et al. MOLECULAR CANCER RESEARCH
- Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
- (2008) M. Okabe et al. MOLECULAR CANCER THERAPEUTICS
- The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
- (2008) C. A. Larson et al. MOLECULAR PHARMACOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab
- (2008) Carolyn Fein Levy et al. PEDIATRIC BLOOD & CANCER
- Small cell undifferentiated variant of hepatoblastoma: Adverse clinical and molecular features similar to rhabdoid tumors
- (2008) Angela D. Trobaugh-Lotrario et al. PEDIATRIC BLOOD & CANCER
- Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes
- (2007) Hiroaki Yamaguchi et al. CANCER LETTERS
- Bcl-2 Gene Silencing in Pediatric Epithelial Liver Tumors
- (2007) Steven W. Warmann et al. JOURNAL OF SURGICAL RESEARCH
- DNA repair in response to anthracycline–DNA adducts: A role for both homologous recombination and nucleotide excision repair
- (2007) Damian M.S. Spencer et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started